Pure Global AI
PVP / MSPSSN / DMP Arrêté

Arrêté N°0036/PVP/MSPSSN/CABPVPM/DMP — signé le 23 février 2016

Conditions de la publicité faite par les laboratoires des produits pharmaceutiques — dispositions expresses pour les dispositifs médicaux
GabonPremier Vice-Premier Ministre, Ministre de la Santé, de la Prévoyance Sociale et de la Solidarité NationaleLabelingCurrentness under review
Official source linked
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

Arrêté N°0036/PVP/MSPSSN/CABPVPM/DMP — signé le 23 février 2016 is the official PVP / MSPSSN / DMP identifier for “Conditions de la publicité faite par les laboratoires des produits pharmaceutiques — dispositions expresses pour les dispositifs médicaux”. Arrêté N°0036/PVP/MSPSSN/CABPVPM/DMP — signé le 23 février 2016 is the official identifier PVP / MSPSSN / DMP uses for this instrument.

Instrument
Arrêté
Full name
Arrêté N°0036/PVP/MSPSSN/CABPVPM/DMP — signé le 23 février 2016
Category
Labeling
Source links
Source publication
French
Open the source text
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Read the full text →
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

French full textFrench — reviewed original textRead HTML →
About this regulation

Conditions de la publicité faite par les laboratoires des produits pharmaceutiques — dispositions expresses pour les dispositifs médicaux

Original signed Order 0036, with its complete seven-page instrument and source images. It expressly covers medical-device advertising: Article 2(b) defines device advertising and exclusions; Article 3 requires objective product, performance and conformity claims; Articles 8 and 9 establish VPM for registered devices and a three-month evaluation period starting the day after the filing period ends. Articles 22 and 23 require the stated public advertising visas and link them to changes in device registration attestations. Drug-only AMMG, posology and multidrug provisions retain their express product scope and are not generalized to devices. Article 24 refers fees to regulation without fixing a numeric amount. Article 26 repeals contrary earlier provisions only and does not name the separate Order 0090 of 11 April 2016; no whole-instrument repeal or precedence is inferred. The signature date is read from physical page 7, not from the June 2026 website upload date. Currentness, the relationship between the two numbered advertising orders and any post-2026 implementing chain remain unverified.

Arrêté N°0036/PVP/MSPSSN/CABPVPM/DMP — signé le 23 février 2016 is the official identifier PVP / MSPSSN / DMP uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.

Source linked